Long-acting RNA therapeutics for chronic disease management in companion animals.We develop long-acting siRNA-based programs designed to support durable effects with infrequent dosing, addressing unmet needs in companion animal health.
About Aivena
Aivena Biosciences, Inc. is a biotechnology company developing long-acting RNA therapeutics based on advanced siRNA design and proprietary enabling technologies.
Our initial focus is chronic disease management in companion animals, where durable and infrequent dosing can improve long-term outcomes and treatment compliance.
We operate with a strong commitment to quality, innovation, and disciplined execution.
Focus
• Initial focus: chronic disease management in companion animals
• Modality: long-acting RNA therapeutics (siRNA)
• Approach: quality-first development with disciplined execution
Contact
Aivena Biosciences, Inc. All rights reserved.